scispace - formally typeset
O

Ole Köhler

Researcher at Aarhus University Hospital

Publications -  14
Citations -  1316

Ole Köhler is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Hazard ratio & Randomized controlled trial. The author has an hindex of 9, co-authored 14 publications receiving 996 citations. Previous affiliations of Ole Köhler include Lundbeck & Aarhus University.

Papers
More filters
Journal ArticleDOI

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.

Ole Köhler, +6 more
- 01 Dec 2014 - 
TL;DR: The analysis suggests that anti-inflammatory treatment, in particular celecoxib, decreases depressive symptoms without increased risks of adverse effects, and supports a proof-of-concept concerning the use of anti- inflammatory treatment in depression.
Journal ArticleDOI

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.

Ole Köhler, +3 more
- 30 Sep 2016 - 
TL;DR: Questions and challenges that seem most important and relevant to future studies, such as timing, most effective treatment lengths and identification of subgroups of patients potentially responding better to different anti-inflammatory treatment regimens are addressed.
Journal ArticleDOI

Infections and exposure to anti‐infective agents and the risk of severe mental disorders: a nationwide study

Ole Köhler, +12 more
- 01 Feb 2017 - 
TL;DR: This is the first large‐scale study investigating whether infections treated with anti‐infective agents in the primary care setting increase the risks of schizophrenia and affective disorders.
Journal ArticleDOI

The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study

Ole Köhler, +6 more
- 03 May 2016 - 
TL;DR: In a large naturalistic cohort, concomitant treatment with SSRIs and statins resulted in robust advantages compared with SSRI treatment alone, and these advantages were generalized to a more heterogeneous population of SSRI users.
Journal ArticleDOI

Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.

Ole Köhler, +6 more
- 01 Aug 2015 - 
TL;DR: The objective was to investigate treatment effectiveness and safety aspects of concomitant SSRI use with NSAIDs or paracetamol and to establish a protocol for simultaneous evaluation of potential adverse events.